GABAB receptor agonist baclofen improves methamphetamine-induced cognitive deficit in mice

被引:42
作者
Arai, Sawako [2 ]
Takuma, Kazuhiro [2 ]
Mizoguchi, Hiroyuki [2 ,3 ]
Ibi, Daisuke [2 ]
Nagai, Taku [1 ]
Kamei, Hiroyuki [4 ]
Kim, Hyoung-Chun [5 ]
Yamada, Kiyofumi [1 ,2 ,6 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Nagoya, Aichi 4668560, Japan
[2] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Life Sci, Lab Neuropsychopharmacol, Kanazawa, Ishikawa 9201192, Japan
[3] Nagoya Univ, Environm Med Res Inst, Futurist Environm Simulat Ctr, Nagoya, Aichi 4648601, Japan
[4] Meijo Univ, Grad Sch Pharmaceut Sci, Fac Pharm, Lab Clin Pharm Practice & Hlth Care Management, Nagoya, Aichi 4688503, Japan
[5] Kangwon Natl Univ, Coll Pharm, Neuropsychopharmacol & Toxicol Program, Chunchon 200701, South Korea
[6] JST, CREST, Nagoya, Aichi 4668560, Japan
关键词
Baclofen; Cognitive deficit; Methamphetamine; Schizophrenia; VENTRAL TEGMENTAL AREA; RECOGNITION MEMORY; NUCLEUS-ACCUMBENS; DOPAMINE NEURONS; WORKING-MEMORY; SCHIZOPHRENIA; IMPAIRMENT; AMPHETAMINE; SENSITIZATION; CLOZAPINE;
D O I
10.1016/j.ejphar.2008.10.065
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, we investigated the effects of GABA(A) and GABA(B) receptor agonists on the methamphetamine-induced impairment of recognition memory in mice. Repeated treatment with methamphetamine at a dose of 1 mg/kg for 7 days induced an impairment of recognition memory. Baclofen, a GABA(B) receptor agonist, ameliorated the repeated methamphetamine-induced cognitive impairment, although gaboxadol, a GABA(A) receptor agonist, had no significant effect. GABA(B) receptors may constitute a putative new target in treating cognitive deficits in patients suffering from schizophrenia, as well as methamphetamine psychosis. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:101 / 104
页数:4
相关论文
共 26 条
[1]   Involvement of Pallidotegmental Neurons in Methamphetamine- and MK-801-Induced Impairment of Prepulse Inhibition of the Acoustic Startle Reflex in Mice: Reversal by GABAB Receptor Agonist Baclofen [J].
Arai, Sawako ;
Takuma, Kazuhiro ;
Mizoguchi, Hiroyuki ;
Ibi, Daisuke ;
Nagai, Taku ;
Takahashi, Kenji ;
Kamei, Hiroyuki ;
Nabeshima, Toshitaka ;
Yamada, Kiyofumi .
NEUROPSYCHOPHARMACOLOGY, 2008, 33 (13) :3164-3175
[2]   GABA RECEPTOR AGONISTS - PHARMACOLOGICAL SPECTRUM AND THERAPEUTIC ACTIONS [J].
BARTHOLINI, G .
MEDICINAL RESEARCH REVIEWS, 1985, 5 (01) :55-75
[3]   Baclofen blocks the development of sensitization to the locomotor stimulant effect of amphetamine [J].
Bartoletti, M ;
Gubellini, C ;
Ricci, F ;
Gaiardi, M .
BEHAVIOURAL PHARMACOLOGY, 2005, 16 (07) :553-558
[4]   The GABAB agonist baclofen blocks the expression of sensitisation to the locomotor stimulant effect of amphetamine [J].
Bartoletti, M ;
Gubellini, C ;
Ricci, F ;
Gaiardi, M .
BEHAVIOURAL PHARMACOLOGY, 2004, 15 (5-6) :397-401
[5]   GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder [J].
Benes, FM ;
Berretta, S .
NEUROPSYCHOPHARMACOLOGY, 2001, 25 (01) :1-27
[6]   Attenuation of d-amphetamine self-administration by baclofen in the rat:: behavioral and neurochemical correlates [J].
Brebner, K ;
Ahn, S ;
Phillips, AG .
PSYCHOPHARMACOLOGY, 2005, 177 (04) :409-417
[7]   GABAB receptor agonists for the treatment of drug addiction:: a review of recent findings [J].
Cousins, MS ;
Roberts, DCS ;
de Wit, H .
DRUG AND ALCOHOL DEPENDENCE, 2002, 65 (03) :209-220
[8]   Treatment of methamphetamine abuse: research findings and clinical directions [J].
Cretzmeyer, M ;
Sarrazin, MV ;
Huber, DL ;
Block, RI ;
Hall, JA .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2003, 24 (03) :267-277
[9]  
Elvevåg B, 2000, CRIT REV NEUROBIOL, V14, P1
[10]   GABAB receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo [J].
Erhardt, S ;
Mathé, JM ;
Chergui, K ;
Engberg, G ;
Svensson, TH .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 (03) :173-180